“Blood Glucose Device Market & Forecast (SMBG) (Test Strips, Lancet, Meter) – Worldwide Analysis” analyzes the worldwide market for, blood glucose test strips market, blood glucose lancet market and blood glucose meter market. This is the 3rd publication on Glucose Device Market by Renub Research. This report studies separate comprehensive analytics for the 15 countries: United States, European Countries (United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden and Switzerland), BRIC countries (Brazil, Russia, India, China), Australia and Kuwait. Annual estimates and forecast are provided for the period of 2016 through 2020. A nine year historic analysis is also provided for these markets. This 269 page report with 257 Figures and 12 Tables provides a complete analysis of top 15 countries of worldwide self-monitoring blood glucose (SMBG) market.
Self-Monitoring Blood Glucose (SMBG) Device Market is expected to cross over US$ 16 Billion by 2020 as incidence of diabetes is increasing dramatically. It is estimated that 642 Million people will develop the disease by 2040. This is putting pressure on governments and social institutions to take necessary steps to keep the disease in check and avoid complications in order to ensure that diabetic impact is kept to a minimum. United States is the single largest market for SMBG devices market followed by Russia and United Kingdom. However, China has the highest self-monitoring of blood glucose users compared to other countries.
United States, Russia and United Kingdom together hold more than 63 percent of the total test strips market share whereas in blood glucose meter market China is the dominating country. All big players such as Roche, Bayer and Abbott Laboratories are continuously losing their market share.